AVI Biopharma - 2/7

Entry	Author	Date	Location
AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News	Luke Timmerman	10/01/09	Seattle
The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009	Luke Timmerman	09/22/09	Seattle
Trubion Scores $20M, Archus Shuts Down, AVI Biopharma’s Hope for Muscular Dystrophy, & More Seattle-Area Life Sciences News	Luke Timmerman	09/03/09	Seattle
AVI Offers Glimmer of Hope for Muscular Dystrophy, Says UW Neuroscientist Jeff Chamberlain	Luke Timmerman	09/01/09	Seattle
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News	Luke Timmerman	08/27/09	Seattle
Jeff Bezos Invests in Robots, MySpace Confirms iLike Purchase, Cell Therapeutics Sells Stock, & More Seattle-Area Deals News	Gregory T. Huang	08/25/09	Seattle
AVI Nails Down $30M	Luke Timmerman	08/20/09	Seattle
Seattle Genetics Recruits at Warp Speed, Amgen Passes Cancer Test, Stephen Friend’s Adventure & More Seattle-Area Life Sciences News	Luke Timmerman	08/13/09	Seattle
AVI Ends June With $20M Cash	Luke Timmerman	08/10/09	Seattle
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News	Luke Timmerman	08/06/09	Seattle
AVI Biopharma Bolts from Portland to Seattle to Tap Biotech Talent	Luke Timmerman	07/30/09	Seattle
Dendreon’s Former Boss Predicts Takeover, Covance Buys Merck Lab, How NanoString Got $30M, & More Seattle-Area Life Sciences News	Luke Timmerman	07/30/09	Seattle
AVI Gets Duchenne Funding	Luke Timmerman	07/28/09	Seattle
Dendreon May Not Survive Its Success: Q&A with Founder Chris Henney, Part 2	Luke Timmerman	07/28/09	Seattle
AVI BioPharma Obtains $1,200,000 New Funding Round	VentureDeal	07/28/09	Seattle
Cell Therapeutics Ships App to FDA, Targeted Genetics Cuts Again, Sanofi CEO Looks to Biotech & More Seattle Area Life Sciences News	Luke Timmerman	06/25/09	Seattle
AVI Developing Swine Flu Drugs	Luke Timmerman	06/22/09	Seattle
Dendreon Resists Urge to Sell Out, NanoString Nabs $30M, VC Firm Cashes Out on OncoGenex, & More Seattle-Area Life Sciences News	Luke Timmerman	06/11/09	Seattle
AVI Gets $3M For Muscular Dystrophy	Luke Timmerman	06/04/09	Seattle
Dendreon’s Hiring Binge, Calistoga’s Venture Round, ZymoGenetics Unloads Drugs, & More Seattle-Area Life Sciences News	Luke Timmerman	05/07/09	Seattle
AVI Wins Part of $2.5M Contract	Luke Timmerman	05/06/09	Seattle
Dendreon Drug Prolongs Life, ZymoGenetics Cuts Staff, Microsoft Tackles Biotech & More Seattle-Area Life Sciences News	Luke Timmerman	04/30/09	Seattle
Ebola Fighter AVI Biopharma Gears Up for Biodefense Contracts	Luke Timmerman	04/29/09	Seattle
AVI Gets Patent For Ebola Drug	Luke Timmerman	04/28/09	Seattle
The Northwest Biotech Survival Index 2: Companies Scraping By in Downturn	Luke Timmerman	03/25/09	Seattle
CG Therapeutics, Immune-Booster For Cancer, Recruits Dendreon Vets, New CEO	Luke Timmerman	03/10/09	Seattle
Seattle Genetics Defies Gravity With Biotech’s First Underwritten Stock Sale in Six Months	Luke Timmerman	02/05/09	Seattle
Pathway Medical Gets Traction, Ekos Raises $12.5M, ZymoGenetics Sales Boss Departs, & More Seattle-Area Life Sciences News	Luke Timmerman	02/05/09	Seattle
Lenovo Buys Switchbox, Ekos Raises $12.5M, nLight Lands $10.7M, & More Seattle-Area Deals News	Gregory T. Huang	02/03/09	Seattle
Ebola Fighter, AVI, Raises $16.5M	Luke Timmerman	01/30/09	Seattle
Page 2 of 3	« previous page · next page »

Entry

Author

Date

Location

AVI Settles In, ZymoGenetics MS Drug Fails, Dendreon’s FDA Filing Set for Mid-November & More Seattle-Area Life Sciences News

Luke Timmerman

10/01/09

Seattle

The Seattle Biotech Survival Index: Companies Bounce Back in Mid-2009

Luke Timmerman

09/22/09

Seattle